Showing results (1-10 of 582) with videos related to
Sort By:
Pageof 59
Drugs & Aging|April 1, 1996
Thrombolytic therapy in the elderly. Pharmacoeconomic considerationsK Ramanathan, C J Ellis, H D WhiteAustralian and New Zealand Journal of Medicine|October 20, 1998
Low molecular weight heparins in acute ischaemic syndromesH D White, C J Ellis, J K FrenchAustralian and New Zealand Journal of Medicine|October 20, 1998
New antiplatelet agentsH D White, J K French, C J EllisAustralian and New Zealand Journal of Medicine|October 20, 1998
Thrombolytic eligibilityC J Ellis, J K French, H D WhiteAustralian and New Zealand Journal of Medicine|October 20, 1998
The corrected TIMI frame count. The new gold standard?J K French, C J Ellis, H D WhiteThe American Journal of Cardiology|April 4, 1998
Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severityJ K French, C J Ellis, B J Webber, et al.Australian and New Zealand Journal of Medicine|October 20, 1998
Hirudin (desirudin) and Hirulog (bivalirudin) in acute ischaemic syndromes and the rationale for the Hirulog/Early Reperfusion Occlusion (HERO-2) StudyH D White, C J Ellis, J K French, et al.Heart (British Cardiac Society)|May 25, 1999
Waiting times and prioritization for coronary artery bypass surgery in New ZealandM E Seddon, J K French, D J Amos, et al.The New Zealand Medical Journal|February 11, 1999
Inadequate control of lipid levels in patients with a previous myocardial infarctionC J Ellis, A Zambanini, J K French, et al.Journal of the American College of Cardiology|June 17, 1998
Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarctionJ T Stewart, J K French, P Théroux, et al.Pageof 59